Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-09-17

Clinical Trial Update: Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating Coenzyme Q10 effects on semen parameters in men with idiopathic infertility has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: PharmEvo Pvt Ltd | Conditions: Idiopathic Infertility | Phase 4 | Status: WITHDRAWN